Key points are not available for this paper at this time.
Patients with lichen planus (LP) refractory to available therapies often experience a high disease burden, representing a population with a clear unmet need for new treatments.
Building similarity graph...
Analyzing shared references across papers
Loading...
Passeron et al. (Mon,) studied this question.
synapsesocial.com/papers/68e6a4f8b6db64358762829d — DOI: https://doi.org/10.1093/bjd/ljae181
Thierry Passeron
Inserm
Maximilian Reinhardt
Novartis (Switzerland)
Benjamin D. Ehst
Oregon Medical Research Center
British Journal of Dermatology
Inserm
University of California, Davis
Friedrich-Alexander-Universität Erlangen-Nürnberg
Building similarity graph...
Analyzing shared references across papers
Loading...
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: